Nanoemulsions: Formulation, characterization, biological fate, and potential role against COVID-19 and other viral outbreaks
Authors:
Open Access
- 20 October 2021
- journal article
- research article
- Published by Elsevier in Colloid and Interface Science Communications
- Vol. 45, 100533
Abstract
No abstract availableKeywords
This publication has 220 references indexed in Scilit:
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virusBiochemical Journal, 2012
- Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systemsInternational Journal of Pharmaceutics, 2011
- A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced DiseasePLOS ONE, 2011
- Intranasal Immunization of Ferrets with Commercial Trivalent Influenza Vaccines Formulated in a Nanoemulsion-Based AdjuvantClinical and Vaccine Immunology, 2011
- Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species TransmissionJournal of Virology, 2010
- Rhamnolipids: diversity of structures, microbial origins and rolesApplied Microbiology and Biotechnology, 2010
- Squalene Emulsions for Parenteral Vaccine and Drug DeliveryMolecules, 2009
- The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like ParticlesJournal of Virology, 2008
- Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal VaccinePLOS ONE, 2008
- Mechanism of Inactivation of Enveloped Viruses by the Biosurfactant Surfactin fromBacillus subtilisBiologicals, 1997